Stem cell therapies for the lysosomal storage diseases - the quintessential neurodegenerative diseases.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Current Stem Cell Research & Therapy

• Publication date

  2008-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/157488808784223041PMID 18473875
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells

  2007cited by this paper
• Clinical trials with adult stem/progenitor cells for tissue repair: let's not overlook some essential precautions.

  2007cited by this paper
• Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease

  2007cited by this paper
• Stem cells for multiple sclerosis: promises and reality.

  2007cited by this paper
• Substrate reduction therapy of glycosphingolipid storage disorders

  2006cited by this paper
• Mammalian Stem Cells

  2006cited by this paper
• Identification of Sites of Mannose 6-Phosphorylation on Lysosomal Proteins*

  2006cited by this paper
• Results of the cord blood transplantation study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases.

  2006cited by this paper
• Preclinical evaluation of adult stem cell engraftment and toxicity in the CNS of rhesus macaques.

  2006cited by this paper
• In vitro analysis of multipotent mesenchymal stromal cells as potential cellular therapeutics in neurometabolic diseases in pediatric patients.

  2006cited by this paper
• Mesenchymal Stem Cells Spontaneously Express Neural Proteins in Culture and Are Neurogenic after Transplantation

  2006cited by this paper
• Functional engraftment of human ES cell–derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes

  2006cited by this paper
• Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation

  2005cited by this paper
• Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice.

  2005cited by this paper
• Safety and efficacy of enzyme replacement therapy in combination with hematopoietic stem cell transplantation in Hurler syndrome

  2005cited by this paper
• Biomarkers in lysosomal storage diseases: a review

  2005cited by this paper
• Lentivirus-Mediated Gene Transfer to the Central Nervous System: Therapeutic and Research Applications

  2005cited by this paper
• Differentiation of mesenchymal stem cells into dopaminergic neuron-like cells in vitro.

  2005cited by this paper
• Human mesenchymal stem cells modulate allogeneic immune cell responses.

  2005cited by this paper
• Ablative allogeneic hematopoietic cell transplantation in adults 60 years of age and older.

  2005cited by this paper
• Gene therapy for severe combined immunodeficiencies

  2005cited by this paper
• Acute metabolic encephalopathy: An introduction

  2005cited by this paper
• Plasticity of Cultured Mesenchymal Stem Cells: Switch from Nestin‐Positive to Excitable Neuron‐Like Phenotype

  2005cited by this paper
• Graft-vs-host disease after non-myeloablative hematopoietic cell transplantation

  2005cited by this paper
• Neural Cell Differentiation In Vitro from Adult Human Bone Marrow Mesenchymal Stem Cells

  2005cited by this paper
• Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness.

  2005cited by this paper
• Pre‐ and post‐engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients

  2005cited by this paper
• Correlation between enzyme activity and substrate storage in a cell culture model system for Gaucher disease

  2004cited by this paper
• Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1α/CXC chemokine receptor 4 pathway

  2004cited by this paper
• Primary central nervous system posttransplant lymphoproliferative disorders.

  2004cited by this paper
• Enzyme replacement and enhancement therapies for lysosomal diseases

  2004cited by this paper
• Self-renewal of teratocarcinoma and embryonic stem cells

  2004cited by this paper
• The Pathology of Human Spinal Cord Injury: Defining the Problems

  2004cited by this paper
• Derivation of Human Embryonic Stem Cells from Day‐8 Blastocysts Recovered after Three‐Step In Vitro Culture

  2004cited by this paper
• Human Embryonic Stem Cells Possess Immune‐Privileged Properties

  2004cited by this paper
• Migration of Mesenchymal Stem Cells Through Cerebrospinal Fluid into Injured Spinal Cord Tissue

  2004cited by this paper
• SDF‐1 (CXCL12) Is Upregulated in the Ischemic Penumbra Following Stroke: Association with Bone Marrow Cell Homing to Injury

  2004cited by this paper
• Recent advances in newborn screening for neurometabolic disorders

  2004cited by this paper
• NSAIDs increase survival in the Sandhoff disease mouse: Synergy with N‐butyldeoxynojirimycin

  2004cited by this paper
• Intracerebral Transplantation of Adult Mouse Neural Progenitor Cells into the Niemann-Pick-A Mouse Leads to a Marked Decrease in Lysosomal Storage Pathology

  2004cited by this paper
• Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy

  2004cited by this paper
• Lysosomal storage disorders: the need for better pediatric recognition and comprehensive care.

  2004cited by this paper
• Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and -DRB1 genomically identical volunteers?

  2004cited by this paper
• Human embryonic stem cells: A potential source for cellular therapy

  2004cited by this paper
• Lysosomal storage diseases market

  2004cited by this paper
• Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors

  2003cited by this paper
• Postnatal development of inflammation in a murine model of Niemann-Pick type C disease: immunohistochemical observations of microglia and astroglia.

  2003cited by this paper
• The status of hematopoietic stem cell transplantation in lysosomal storage disease.

  2003cited by this paper
• The immunological properties of adult hippocampal progenitor cells.

  2003cited by this paper
• Neural Progenitor Cells Lack Immunogenicity and Resist Destruction as Allografts

  2003cited by this paper
• Lysosomal storage disorders: emerging therapeutic options require early diagnosis

  2003cited by this paper
• Isolation and characterization of neural progenitor cells from post‐mortem human cortex

  2003cited by this paper
• Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis.

  2003cited by this paper
• Brain transplantation of genetically engineered human neural stem cells globally corrects brain lesions in the mucopolysaccharidosis type VII mouse

  2003cited by this paper
• Biology of human bone marrow stem cells

  2003cited by this paper
• Neprilysin Gene Transfer Reduces Human Amyloid Pathology in Transgenic Mice

  2003cited by this paper
• CXCR4 Regulates Interneuron Migration in the Developing Neocortex

  2003cited by this paper
• Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis

  2003cited by this paper
• Engraftment of sorted/expanded human central nervous system stem cells from fetal brain

  2002cited by this paper
• The International Bone Marrow Transplant Registry

  2002cited by this paper
• Role of the chemokine SDF-1 as the meningeal attractant for embryonic cerebellar neurons

  2002cited by this paper
• Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH)

  2002cited by this paper
• Expression of the Chemokine Receptor CXCR4 and Its Ligand Stromal Cell‐Derived Factor 1 in Human Brain Tumors and Their Involvement in Glial Proliferation in Vitro

  2002cited by this paper
• Intracerebral transplantation of mesenchymal stem cells into acid sphingomyelinase-deficient mice delays the onset of neurological abnormalities and extends their life span.

  2002cited by this paper
• Progress and controversies in the treatment of pediatric acute myelogenous leukemia

  2002cited by this paper
• Adenovirus-mediated prenatal gene transfer to murine central nervous system

  2002cited by this paper
• Expansion of Human Adult Stem Cells from Bone Marrow Stroma: Conditions that Maximize the Yields of Early Progenitors and Evaluate Their Quality

  2002cited by this paper
• Enzyme replacement and enhancement therapies: lessons from lysosomal disorders

  2002cited by this paper
• The chemokine SDF1 regulates migration of dentate granule cells.

  2002cited by this paper
• Cell culture. Progenitor cells from human brain after death.

  2001cited by this paper
• Inborn errors of metabolism

  2001cited by this paper
• Homing of Human Hematopoietic Stem and Progenitor Cells: New Insights, New Challenges?

  2001cited by this paper
• Bone Marrow Stem Cell Gene Therapy of Arylsulfatase A-Deficient Mice, Using an Arylsulfatase A Mutant That Is Hypersecreted from Retrovirally Transduced Donor-Type Cells

  2001cited by this paper
• Embryonic-derived glial-restricted precursor cells (GRP cells) can differentiate into astrocytes and oligodendrocytes in vivo.

  2001cited by this paper
• Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation.

  2000cited by this paper
• Embryonic stem cell-derived glial precursors: a source of myelinating transplants.

  1999cited by this paper
• "Global" cell replacement is feasible via neural stem cell transplantation: evidence from the dysmyelinated shiverer mouse brain.

  1999cited by this paper
• Human Neural Stem Cells: Isolation, Expansion and Transplantation

  1999cited by this paper
• Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord

  1999cited by this paper
• Transduced Fibroblasts and Metachromatic Leukodystrophy Lymphocytes Transfer Arylsulfatase A to Myelinating Glia and Deficient Cells In Vitro

  1998cited by this paper
• Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy.

  1998cited by this paper
• Biology and potential strategies for the treatment of GM2 gangliosidoses.

  1998cited by this paper
• Adenovirus-mediated gene transfer results in decreased lysosomal storage in brain and total correction in liver of aspartylglucosaminuria (AGU) mouse

  1998cited by this paper
• Diagnosis and management of glutaric aciduria type I

  1998cited by this paper
• Embryonic stem cell lines derived from human blastocysts.

  1998cited by this paper
• Understanding the molecular basis of cell migration; implications for clinical therapy in multiple sclerosis.

  1997cited by this paper
• Expression of human beta-hexosaminidase alpha-subunit gene (the gene defect of Tay-Sachs disease) in mouse brains upon engraftment of transduced progenitor cells.

  1996cited by this paper
• Bone marrow transplantation therapy for metabolic disease: animal models as predictors of success and in utero approaches.

  1996cited by this paper
• Neural progenitor cell engraftment corrects lysosomal storage throughout the MRS VII mouse brain

  1995cited by this paper
• In utero hematopoietic stem cell transplants for inherited diseases.

  1994cited by this paper
• Research update on lysosomal disorders with special emphasis on metachromatic leukodystrophy and Krabbe disease.

  1993cited by this paper
• Recombinant human iduronate-2-sulphatase: correction of mucopolysaccharidosis-type II fibroblasts and characterization of the purified enzyme.

  1993cited by this paper
• Prenatal diagnosis of lysosomal storage diseases

  1984cited by this paper
• Partial enzyme deficiencies: residual activities and the development of neurological disorders.

  1983cited by this paper
• ENZYMOLOGICAL DIAGNOSIS OF A GROUP OF LYSOSOMAL STORAGE DISEASES: REVIEW OF 5‐YEAR EXPERIENCE OF 1600 PATIENT‐SAMPLE REFERRALS

  1980cited by this paper

• Culturing Human Pluripotent and Neural Stem Cells in an Enclosed Cell Culture System for Basic and Preclinical Research

  2016cites this paper
• A novel, long-lived, and highly engraftable immunodeficient mouse model of mucopolysaccharidosis type I

  2015cites this paper
• Central nervous system stem cell transplantation for children with neuronal ceroid lipofuscinosis.

  2013cites this paper
• The Nature of the Pediatric Brain and Its Associated Diseases Precludes Adult Surrogates for Testing Intracranial Stem Cell-Based Transplantation Strategies

  2012cites this paper
• Neural Stem Cell Transplantation as a Therapeutic Approach for Treating Lysosomal Storage Diseases

  2011cites this paper
• Cellular pathogenesis in sphingolipid storage disorders: the quest for new therapeutic approaches

  2010cites this paper
• Stem cell transplantation for neurometabolic and neurodegenerative diseases.

  2010cites this paper
• Transplantation tolerance in an age of induced pluripotency

  2009cites this paper